Welcome!

News Feed Item

Orthopaedics: Market Prospects & Global Competition

NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Orthopaedics: Market Prospects & Global Competition

http://www.reportlinker.com/p01054660/Orthopaedics-Market-Prospects--Global-Competition .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

Growth in the global orthopaedic market is projected to be 8% over the period 2012-17. By 2017, orthopaedic revenues are expected to total US$51.1 billion compared with US$34.7 billion in 2012 - but which companies are driving this growth?

The orthopaedic market has not been immune to the economic downturn that has plagued world economies in recent times. Some of the smaller companies, particularly those at the cutting edge of the market, found themselves short of cash and with little in the way of white knights to help make up the shortfall.

Now things are slowly changing. Private equity has returned to the industry and some of those calls for cash are finally getting answered by investors. It has become noticeable that a number of these investors have been able to successfully sell some of their business holdings with their pride relatively intact. And the reasons why we need these devices are growing ever more present.

The strength of the orthopaedics sector is that the fundamentals remain strong. It is one of the fastest growing sectors in the industry, thanks to the impact of an expanding elderly population and the associated steady rise and diagnosis in musculoskeletal disorders.

Use this new report to easily answer key business questions such as:

What developments will underpin the 2012-17 CAGR of 8.2% in the artificial joint sector?

What new products and services has Integra LifeSciences introduced in 2012?

What is the product and service line of the newly merged DePuy Synthes?

What are the latest developments in worldwide regulation and how are they affecting the orthopaedic sector?

Does ConforMIS patented i-fit technology signal progression on the development of bespoke, patient specific implants?

Which company posted flat sales in the US but grew revenues in Europe and Asia by 10% and 16% respectively in 2011?

Who is active in the foot and ankle ortho sector and what are their competing products?

A complete analysis packed with facts, forecasts and

detailed company evaluations

Regulation: First Approval – why some companies prefer Europe over the USA

There is increasing concern from manufacturers that access to the world's largest orthopaedic market is being frustrated by the FDA's lengthy and costly approval process. Some companies have made conscious efforts to avoid the US market, citing the expense and uncertainty of the FDA process as the reasons. Indeed, it is often seen as a preferred option for US start-ups to find their feet - and their revenues - in the European market. Faced without the possibility of much needed revenue, a massive regulatory bill and a nervy team of investors, companies eyeing the US market are required to sit tight as the FDA goes through its safety and efficacy review processes.

Study shows the contrasts

The contrast in regulatory approaches in Europe could not be clearer. According to a 2010 Stanford University study in the US, entitled "FDA Impact on US Medical Technology Innovation, for a PMAtype product, the time span from the initial contact with the regulatory authority until market launch amounted to 54 months in the US, compared with 11 months in Europe. On average, a market launch in Europe can be realised three years earlier, with significantly lower costs. Financially, it can take a device manufacturer three to five years to get a medical device approved in Japan and China, at a cost of US$3 million or less in each market. In Europe, the time can range from six months to two years and cost around US$2 million. In contrast, getting approval in the US for a medical device can take between two and seven years and cost between US$50 to US$100 million. Time frames differ for those pursuing the 510(k) route to approval, but even here the FDA's anxieties can be seen in requests for further information after first review: 3 out of 4 applications will now be referred back to the company. The trend, illustrated in the chart below, shows that this is long established.

CONTENTS

INTRODUCTION..1

AN OVERVIEW OF REGULATORY ISSUES IN THE US, EUROPE AND BEYOND ..3

ORTHOPAEDIC COMPANIES FIVE-YEAR SALES REVIEW.23

AAP IMPLANTATE25

KEY PERSONNEL..25

COMPANY OVERVIEW .25

KEY MILESTONES 25

AGREEMENTS.26

TECHNOLOGIES/PRODUCTS27

KEY FINANCIAL DATA30

ALPHATEC SPINE.31

KEY PERSONNEL..31

COMPANY OVERVIEW .31

KEY COMPETITORS 31

KEY MILESTONES 31

AGREEMENTS.32

TECHNOLOGIES/PRODUCTS34

KEY FINANCIAL DATA41

AMEDICA..43

KEY PERSONNEL..43

COMPANY OVERVIEW .43

KEY MILESTONES 43

AGREEMENTS 44

TECHNOLOGIES/PRODUCTS45

KEY FINANCIAL DATA47

ANIKA THERAPEUTICS 49

KEY PERSONNEL..49

COMPANY OVERVIEW .49

KEY COMPETITORS 49

KEY MILESTONES 49

AGREEMENTS.50

R&D MILESTONES ..50

TECHNOLOGIES/PRODUCTS50

KEY FINANCIAL DATA51

ARTHROCARE 53

KEY PERSONNEL..53

COMPANY OVERVIEW .53

KEY COMPETITORS 53

KEY MILESTONES 53

AGREEMENTS.54

R&D MILESTONES ..54

TECHNOLOGIES/PRODUCTS55

KEY FINANCIAL DATA63

ARTIMPLANT 65

KEY PERSONNEL. 65

COMPANY OVERVIEW 65

KEY MILESTONES .. 65

AGREEMENTS 65

R&D MILESTONES .66

TECHNOLOGIES/PRODUCTS.. 67

KEY FINANCIAL DATA.. 67

BACTERIN INTERNATIONAL 69

KEY PERSONNEL. 69

COMPANY OVERVIEW 69

KEY COMPETITORS .. 69

KEY MILESTONES .. 69

AGREEMENTS 70

R&D MILESTONES . 70

TECHNOLOGIES/PRODUCTS.. 71

KEY FINANCIAL DATA.. 71

BIOMET. 73

KEY PERSONNEL. 73

COMPANY OVERVIEW 73

KEY COMPETITORS .. 73

KEY MILESTONES .. 74

AGREEMENTS 74

R&D MILESTONES . 75

TECHNOLOGIES/PRODUCTS.. 76

SUBSIDIARIES 81

KEY FINANCIAL DATA..88

BIOMIMETIC THERAPEUTICS. 89

KEY PERSONNEL.89

COMPANY OVERVIEW 89

KEY COMPETITORS ..89

KEY MILESTONES ..89

AGREEMENTS 91

R&D MILESTONES . 91

TECHNOLOGIES/PRODUCTS.. 93

KEY FINANCIAL DATA..94

BONESUPPORT 95

KEY PERSONNEL. 95

COMPANY OVERVIEW 95

KEY COMPETITORS .. 95

KEY MILESTONES .. 95

AGREEMENTS 95

TECHNOLOGIES/PRODUCTS..96

KEY FINANCIAL DATA.. 97

CAYENNE MEDICAL.. 99

KEY PERSONNEL.99

COMPANY OVERVIEW 99

KEY MILESTONES ..99

AGREEMENTS99

R&D MILESTONES ..100

PRODUCTS ..100

KEY FINANCIAL DATA 101SEPTEMBER 2012 ESPICOM BUSINESS INTELLIGENCE V

ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION TABLE OF CONTENTS

CO.DON . 103

KEY PERSONNEL..103

COMPANY OVERVIEW .103

KEY COMPETITORS 103

AGREEMENTS.103

R&D MILESTONES ..104

TECHNOLOGIES/PRODUCTS104

KEY FINANCIAL DATA104

CONFORMIS 105

KEY PERSONNEL..105

COMPANY OVERVIEW .105

KEY MILESTONES 105

AGREEMENTS.106

TECHNOLOGIES/PRODUCTS106

KEY FINANCIAL DATA106

CORIN..107

KEY PERSONNEL..107

COMPANY OVERVIEW .107

KEY MILESTONES 107

AGREEMENTS.107

R&D MILESTONES ..108

TECHNOLOGIES/PRODUCTS108

KEY FINANCIAL DATA.111

DEPUY SYNTHES ..113

KEY PERSONNEL113

COMPANY OVERVIEW ..113

KEY COMPETITORS .114

KEY MILESTONES .115

AGREEMENTS..116

TECHNOLOGIES/PRODUCTS.117

KEY FINANCIAL DATA134

DJO GLOBAL 135

KEY PERSONNEL.. 135

COMPANY OVERVIEW . 135

KEY COMPETITORS 135

KEY MILESTONES 135

AGREEMENTS 136

R&D MILESTONES .. 137

TECHNOLOGIES/PRODUCTS 137

KEY FINANCIAL DATA 147

EXACTECH.149

KEY PERSONNEL..149

COMPANY OVERVIEW .149

KEY COMPETITORS 149

KEY MILESTONES 149

AGREEMENTS.150

R&D MILESTONES .. 151

TECHNOLOGIES/PRODUCTS 151

KEY FINANCIAL DATA 157

GLOBUS MEDICAL159

KEY PERSONNEL.. 159

COMPANY OVERVIEW . 159

KEY COMPETITORS 159

KEY MILESTONES 159

R&D MILESTONES ..160

TECHNOLOGIES/PRODUCTS 161

KEY FINANCIAL DATA165

HANGER .167

KEY PERSONNEL.. 167

COMPANY OVERVIEW . 167

KEY COMPETITORS 167

KEY MILESTONES 167

AGREEMENTS.168

R&D MILESTONES ..168

TECHNOLOGIES/PRODUCTS169

KEY FINANCIAL DATA 171

INION173

KEY PERSONNEL.. 173

COMPANY OVERVIEW . 173

KEY MILESTONES 173

AGREEMENTS. 173

R&D MILESTONES 174

TECHNOLOGIES/PRODUCTS.174

KEY FINANCIAL DATA 176

INTEGRA LIFESCIENCES177

KEY PERSONNEL.. 177

COMPANY OVERVIEW . 177

KEY COMPETITORS 177

KEY MILESTONES 177

AGREEMENTS. 181

TECHNOLOGIES/PRODUCTS 181

KEY FINANCIAL DATA 191

K2M193

KEY PERSONNEL.. 193

COMPANY OVERVIEW . 193

KEY MILESTONES 193

AGREEMENTS.195

TECHNOLOGIES/PRODUCTS195

KEY FINANCIAL DATA 197

KANGHUI MEDICAL .. 199

KEY PERSONNEL..199

COMPANY OVERVIEW .199

KEY COMPETITORS 199

KEY MILESTONES 199

AGREEMENTS.200

TECHNOLOGIES /PRODUCTS..200

KEY FINANCIAL DATA202SEPTEMBER 2012 ESPICOM BUSINESS INTELLIGENCE VII

ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION TABLE OF CONTENTS

KFX MEDICAL. 203

KEY PERSONNEL..203

COMPANY OVERVIEW .203

KEY COMPETITORS 203

KEY MILESTONES 203

TECHNOLOGIES/PRODUCTS204

KEY FINANCIAL DATA204

KUROS BIOSURGERY 205

KEY PERSONNEL..205

COMPANY OVERVIEW .205

KEY MILESTONES 205

AGREEMENTS.205

R&D MILESTONES ..206

TECHNOLOGIES/PRODUCTS207

KEY FINANCIAL DATA208

LANX 209

KEY PERSONNEL..209

COMPANY OVERVIEW .209

KEY MILESTONES 209

AGREEMENTS.209

R&D MILESTONES .. 210

TECHNOLOGIES/PRODUCTS 210

KEY FINANCIAL DATA.211

LDR SPINE .213

KEY PERSONNEL.. 213

COMPANY OVERVIEW . 213

KEY COMPETITORS 213

KEY MILESTONES 213

R&D MILESTONES .. 214

TECHNOLOGIES/PRODUCTS 215

KEY FINANCIAL DATA 217

LIFE SPINE.219

KEY PERSONNEL.. 219

COMPANY OVERVIEW . 219

KEY MILESTONES 219

AGREEMENTS.220

TECHNOLOGIES/PRODUCTS220

KEY FINANCIAL DATA222

MAKO SURGICAL. 223

KEY PERSONNEL..223

COMPANY OVERVIEW .223

KEY COMPETITORS 223

KEY MILESTONES 223

AGREEMENTS.224

R&D MILESTONES ..224

TECHNOLOGIES/PRODUCTS224

KEY FINANCIAL DATA226VIII

TABLE OF CONTENTS ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION

MAZOR ROBOTICS . 227

KEY PERSONNEL..227

COMPANY OVERVIEW .227

KEY MILESTONES 227

AGREEMENTS.228

R&D MILESTONES ..228

TECHNOLOGIES/PRODUCTS229

KEY FINANCIAL DATA230

MEDICREA INTERNATIONAL 231

KEY PERSONNEL..231

COMPANY OVERVIEW .231

KEY MILESTONES 231

AGREEMENTS.231

R&D MILESTONES ..232

TECHNOLOGIES/PRODUCTS232

KEY FINANCIAL DATA233

MEDTRONIC 235

KEY PERSONNEL..235

COMPANY OVERVIEW .235

KEY COMPETITORS 235

KEY MILESTONES 236

AGREEMENTS.238

R&D MILESTONES ..239

TECHNOLOGIES/PRODUCTS240

KEY FINANCIAL DATA248

NUVASIVE 249

KEY PERSONNEL..249

COMPANY OVERVIEW .249

KEY COMPETITORS 249

KEY MILESTONES 250

AGREEMENTS.251

R&D MILESTONES ..251

TECHNOLOGIES/PRODUCTS252

KEY FINANCIAL DATA254

ORTHOFIX INTERNATIONAL. 255

KEY PERSONNEL..255

COMPANY OVERVIEW .255

KEY COMPETITORS 255

KEY MILESTONES 256

AGREEMENTS.257

TECHNOLOGIES/PRODUCTS258

KEY FINANCIAL DATA264

PIONEER SURGICAL TECHNOLOGY. 265

KEY PERSONNEL..265

COMPANY OVERVIEW .265

KEY MILESTONES 265

AGREEMENTS.266

R&D MILESTONES ..267

TECHNOLOGIES/PRODUCTS267

KEY FINANCIAL DATA270SEPTEMBER

RTI BIOLOGICS.. 271

KEY PERSONNEL..271

COMPANY OVERVIEW .271

KEY MILESTONES 271

AGREEMENTS.272

R&D MILESTONES ..272

TECHNOLOGIES/PRODUCTS273

KEY FINANCIAL DATA276

SI-BONE. 277

KEY PERSONNEL..277

COMPANY OVERVIEW .277

KEY COMPETITORS 277

KEY MILESTONES 277

R&D MILESTONES ..278

TECHNOLOGIES/PRODUCTS278

KEY FINANCIAL DATA278

SMALL BONE INNOVATIONS 279

KEY PERSONNEL..279

COMPANY OVERVIEW .279

KEY COMPETITORS 279

KEY MILESTONES 279

AGREEMENTS.280

R&D MILESTONES ..281

TECHNOLOGIES/PRODUCTS281

KEY FINANCIAL DATA284

SMITH & NEPHEW .. 285

KEY PERSONNEL..285

COMPANY OVERVIEW .285

KEY COMPETITORS 285

KEY MILESTONES 286

AGREEMENTS 287

R&D MILESTONES ..288

TECHNOLOGIES/PRODUCTS289

KEY FINANCIAL DATA292

SPINAL ELEMENTS . 295

KEY PERSONNEL..295

COMPANY OVERVIEW .295

KEY COMPETITORS 295

KEY MILESTONES 295

AGREEMENTS 295

R&D MILESTONES ..296

TECHNOLOGIES/PRODUCTS296

KEY FINANCIAL DATA297

SPINALMOTION 299

KEY PERSONNEL..299

COMPANY OVERVIEW .299

KEY MILESTONES 299

R&D MILESTONES ..299

TECHNOLOGIES/PRODUCTS300

KEY FINANCIAL DATA300X

SPINESMITH 301

KEY PERSONNEL..301

COMPANY OVERVIEW .301

KEY MILESTONES 301

AGREEMENTS.301

R&D MILESTONES ..302

TECHNOLOGIES/PRODUCTS302

KEY FINANCIAL DATA303

STANMORE IMPLANTS 305

KEY PERSONNEL..305

COMPANY OVERVIEW .305

KEY MILESTONES 305

AGREEMENTS.305

TECHNOLOGIES/PRODUCTS306

KEY FINANCIAL DATA308

STRYKER 309

KEY PERSONNEL..309

COMPANY OVERVIEW .309

KEY COMPETITORS 309

KEY MILESTONES 310

AGREEMENTS..311

R&D MILESTONES 311

TECHNOLOGIES/PRODUCTS 312

KEY FINANCIAL DATA320

SYMMETRY MEDICAL 321

KEY PERSONNEL.. 321

COMPANY OVERVIEW . 321

KEY COMPETITORS 321

KEY MILESTONES ..321

AGREEMENTS 322

TECHNOLOGIES/PRODUCTS323

KEY FINANCIAL DATA325

TORNIER 327

KEY PERSONNEL..327

COMPANY OVERVIEW .327

KEY MILESTONES 327

AGREEMENTS.328

R&D MILESTONES ..328

TECHNOLOGIES/PRODUCTS329

KEY FINANCIAL DATA333

TRANS1.. 335

KEY PERSONNEL..335

COMPANY OVERVIEW .335

KEY COMPETITORS 335

KEY MILESTONES 335

AGREEMENTS.336

TECHNOLOGIES/PRODUCTS336

KEY FINANCIAL DATA337

WRIGHT MEDICAL GROUP 339

KEY PERSONNEL..339

COMPANY OVERVIEW .339

KEY COMPETITORS 339

KEY MILESTONES 339

AGREEMENTS.341

R&D MILESTONES ..341

TECHNOLOGIES/PRODUCTS342

KEY FINANCIAL DATA349

X-SPINE SYSTEMS.351

KEY PERSONNEL..351

COMPANY OVERVIEW .351

KEY MILESTONES 351

AGREEMENTS.351

TECHNOLOGIES/PRODUCTS352

KEY FINANCIAL DATA353

ZIMMER. 355

KEY PERSONNEL..355

COMPANY OVERVIEW .355

KEY COMPETITORS355

KEY MILESTONES 355

AGREEMENTS.357

R&D MILESTONES ..358

TECHNOLOGIES/PRODUCTS359

KEY FINANCIAL DATA368

To order this report:

Orthopedic Industry: Orthopaedics: Market Prospects & Global Competition

Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.
SYS-CON Events announced today that TidalScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale is the leading provider of Software-Defined Servers that bring flexibility to modern data centers by right-sizing servers on the fly to fit any data set or workload. TidalScale’s award-winning inverse hypervisor technology combines multiple commodity servers (including their ass...
In the fast-paced advances and popularity in cloud technology, one of the most critical factors revolves around concerns for security of your critical data. How to assure both your company and your customers they can confidently trust and utilize your cloud environment is most often top on the list. There is a method to evaluating and providing security that exceeds conventional modes of protecting data both within the cloud as well externally on mobile and other devices. With the public failure...
Join IBM November 1 at 21st Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Cognitive analysis impacts today’s systems with unparalleled ability that were previously available only to manned, back-end operations. Thanks to cloud processing, IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Imagine a robot vacuum that becomes your personal assistant tha...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, will provide a fun and simple way to introduce Machine Leaning to anyone and everyone. Together we will solve a machine learning problem and find an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intellige...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
The session is centered around the tracing of systems on cloud using technologies like ebpf. The goal is to talk about what this technology is all about and what purpose it serves. In his session at 21st Cloud Expo, Shashank Jain, Development Architect at SAP, will touch upon concepts of observability in the cloud and also some of the challenges we have. Generally most cloud-based monitoring tools capture details at a very granular level. To troubleshoot problems this might not be good enough.
As popularity of the smart home is growing and continues to go mainstream, technological factors play a greater role. The IoT protocol houses the interoperability battery consumption, security, and configuration of a smart home device, and it can be difficult for companies to choose the right kind for their product. For both DIY and professionally installed smart homes, developers need to consider each of these elements for their product to be successful in the market and current smart homes.
Infoblox delivers Actionable Network Intelligence to enterprise, government, and service provider customers around the world. They are the industry leader in DNS, DHCP, and IP address management, the category known as DDI. We empower thousands of organizations to control and secure their networks from the core-enabling them to increase efficiency and visibility, improve customer service, and meet compliance requirements.
In his session at 21st Cloud Expo, Michael Burley, a Senior Business Development Executive in IT Services at NetApp, will describe how NetApp designed a three-year program of work to migrate 25PB of a major telco's enterprise data to a new STaaS platform, and then secured a long-term contract to manage and operate the platform. This significant program blended the best of NetApp’s solutions and services capabilities to enable this telco’s successful adoption of private cloud storage and launchi...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In their Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, and Mark Lav...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, will discuss how given the magnitude of today's applicati...